Mechanisms of intranasal steroids in the management of upper respiratory allergic diseases

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 4 I, 1999, Pages

  Nelson, Harold S ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Allergic rhinitis; Chemokines; Cytokines; Intranasal steroids; Mechanisms of action

Indexed keywords

CHEMOKINE; CORTICOSTEROID; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 16; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CYTOKINE RELEASE; DRUG EFFICACY; DRUG MECHANISM; EFFECTOR CELL; IMMUNE RESPONSE; PRIORITY JOURNAL;

EID: 0033495781     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(99)70309-x     Document Type: Article

References (30)

1. Bascom R, Wachs M, Naclerio RM, Pipkorn U, Galli SJ, Lichtenstein LM. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Inimunol 1988;81:580-9.
2. Andersson M, Andersson P, Pipkorn U. Topical glucocorticosteroids and allergen-induced increase in nasal reactivity: relationship between treatment time and inhibitory effect. J Allergy Clin Immunol 1988;82:1019-26.
3. Small P, Black M, Frenkiel S. Effects of treatment with beclomethasone dipropionate in subpopulations of perennial rhinitis patients. J Allergy Clin Immunol 1982;70:178-82.
4. Malm L, Wihl JA, Lamm CJ, Lindqvist N. Reduction of methacholine-induced nasal secretion by treatment with a new topical steroid in perennial non-allergic rhinitis. Allergy 1981;36:209-14.
5. Howarth PH. The cellular basis for allergic rhinitis. Allergy 1995;50(23 Suppl):6-10.
6. Fokkens WJ, Godthelp T, Holm AF, Blom H, Klein-Jan A. et al. Allergic rhinitis and inflammation: the effect of nasal cortiocsteroid therapy. Allergy 1997;52:29-32.
7. Meltzer EO. Nasal cytological changes following pharmacological intervention. Allergy 1995;50(23 Suppl):15-20.
8. Her E, Frazer J, Austen KF, Owen WF. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils: cytokine and glucocorticoid effcts on eosinophils maintained by endothelial cell conditioning medium. J Clin Invest 1992;88:1982-7.
9. Lozewicz S, Wang J, Duddle J, Thomas K, Chalstrey S, Reilly G, et al. Topical glucocorticoid s inhibit activation by allergen in the upper respiratory tract. J Allergy Clin Immunol 1992;89:951-7.
10. Klementsson H, Svensson C, Andersson M, Venge P, Pipkorn U, Persson CGA. Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a weak pollen season. Clin Exp Allergy 1991;21:705-10.
11. Okuda M, Sakaguchi K, Ohtsuka H. Intranasal beclomethasone: mode of action in nasal allergy. Ann Allergy 1983;50:116-20.
12. Pipkorn U. Effect of topical glucocorticoid treatment on nasal mucosal mast cells in allergic rhinitis. Allergy 1983;38:125-9.
13. Mygind N, Dahl R. The rationale for use of topical corticosteroids in allergic rhinitis. Clin Exp Allergy 1996;26(3 Suppl):2-10.
14. Svensson C, Klementsson H, Andersson M, Pipkorn U, Alkner U, Persson CGA. Glucocorticoid-induced attenuation of mucosal exudation of fibrinogen and bradykinins in seasonal allergic rhinitis. Allergy 1994;49:177-83.
15. Baroody FM, Rouadi P, Driscoll PV, Bochner BS, Naclerio RM. Intranasal beclomethasone reduces allergen-induced symptoms and superficial mucosal eosinophilia without affecting submucosal inflammation. Am J Respir Crit Care Med 1998;157:899-906.
16. Sim TC, Reece LM, Hilsmeier KA, Grant A, Alam R. Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment. Am J Respir Crit Care Med 1995;152:927-33.
17. Ghaffar O, Laberge S, Jacobson MR, Lowhagen O, Rak S, Durham SR, et al. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy. Am J Respir Cell Mol Biol 1997;17:17-24.
18. Masuyama K, Jacobson MR, Rak S, Meng Q, Sudderick RM, Kay AB, et al. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology 1994;82:192-9.
19. e RNA in the nasal mucosa of patients with seasonal rhinitis: effect of topical corticosteroids. J Allergy Clin Immunol 1998;101:330-6.
20. Bradding P, Feather IH, Wilson S, Holgate ST, Howorth PH. Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid. Am J Respir Crit Care Med 1995;151:1900-6.
21. Pullerits T, Praks L, Sjostrand M, Jrak S, Skoogh BE, Lotvall J. An intranasal glucocorticoid inhibits the increase of specific IgE initiated during birch pollen season. J Allergy Clin Immunol 1997;100:601-5.
22. Naclerio RM, Adkinson NE Jr, Creticos PS, Baroody FM, Hamilton RG, Norman PS. Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies. J Allergy Clin Immunol 1993;92:717-21.
23. Laberge JS, Durham SR, Ghaffar O, Rak S, Center DM, Jacobson M, et al. Expression of IL-16 in allergen-induced late-phase nasal responses and relation to topical glucocorticosteroid treatment. J Allergy Clin Immunol 1997;100:569-74.
24. Kim YK, Nakagawa N, Nakano K, Sulakvelidze I, Dolovich J, Denburg J. Stem cell factor in nasal polyposis and allergic rhinitis: increased expression by structural cells is suppressed by in vivo topical cortico steroids. J Allergy Clin Immunol 1997;100:389-99.
25. Roca-Ferrer J, Mullol J, Loez E, Xaubet A, Pujois L, Fernandez JC, et al. Effect of topical anti-inflammatory drugs on epithelial cell-induced eosinophil survival and GM-CSF secretion. Eur Respir J 1997;10:1489-95.
26. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992:148:2390-4.
27. Holm AF, Fokkens WJ, Godthelp T, Mulder PG, Vroom TM, Rijntjes E. Effect of 3 months nasal steroid therapy on nasal T cells and Langerhans cells in patients suffering from allergic rhinitis. Allergy 1995;50:204-9.
28. Varney A, Jacobson MR, Sudderick RM, Robinson DS, Irani AMA, Schwartz B, et al. Immunohistology of the nasal mucosa following allergen-induced rhinitis. Am Rev Respir Dis 1992;146:170-6.
29. Calderón MA, Lozewicz S, Prior A, Jordan S, Trigg CJ, Davies RJ. Lymphocyte infiltration and thickness of the nasal mucous membrane in perennial and seasonal allergic rhinitis. J Allergy Clin Immunol 1994;93:635-43.
30. Kanai N, Denburg J, Jordana M, Dolovich J. Nasal polyp inflammation: effect of topical nasal steroids. Am J Respir Crit Care Med 1994; 150:1094-1100.